The major marker attributed to high-risk neuroblastoma is MYCN gene amplification and high-risk neuroblastoma patients without MYCN-amplification frequently exhibit high expression of either MycN, c-Myc, or Myc signature genes [19]. Here, MYCN is linked to neuroblastoma.